- Home
- NFBK vs PSNL Comparison
NFBK vs PSNL Comparison
Compare NFBK & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NFBK
- PSNL
- Stock Information
- Founded
- NFBK 1887
- PSNL 2011
- Country
- NFBK United States
- PSNL United States
- Employees
- NFBK N/A
- PSNL N/A
- Industry
- NFBK Major Banks
- PSNL Medical Specialities
- Sector
- NFBK Finance
- PSNL Health Care
- Exchange
- NFBK Nasdaq
- PSNL Nasdaq
- Market Cap
- NFBK 406.5M
- PSNL 460.7M
- IPO Year
- NFBK 2007
- PSNL 2019
- Fundamental
- Price
- NFBK $9.66
- PSNL $3.19
- Analyst Decision
- NFBK Hold
- PSNL Strong Buy
- Analyst Count
- NFBK 2
- PSNL 5
- Target Price
- NFBK $13.00
- PSNL $7.80
- AVG Volume (30 Days)
- NFBK 190.8K
- PSNL 733.3K
- Earning Date
- NFBK 04-28-2025
- PSNL 05-07-2025
- Dividend Yield
- NFBK 5.37%
- PSNL N/A
- EPS Growth
- NFBK N/A
- PSNL N/A
- EPS
- NFBK 0.72
- PSNL N/A
- Revenue
- NFBK $127,026,000.00
- PSNL $84,614,000.00
- Revenue This Year
- NFBK $9.86
- PSNL N/A
- Revenue Next Year
- NFBK $15.23
- PSNL $27.78
- P/E Ratio
- NFBK $13.42
- PSNL N/A
- Revenue Growth
- NFBK N/A
- PSNL 15.15
- 52 Week Low
- NFBK $6.98
- PSNL $1.14
- 52 Week High
- NFBK $14.39
- PSNL $7.20
- Technical
- Relative Strength Index (RSI)
- NFBK 33.39
- PSNL 42.50
- Support Level
- NFBK $9.46
- PSNL $2.86
- Resistance Level
- NFBK $10.06
- PSNL $3.40
- Average True Range (ATR)
- NFBK 0.56
- PSNL 0.33
- MACD
- NFBK -0.06
- PSNL 0.04
- Stochastic Oscillator
- NFBK 14.86
- PSNL 40.27
About NFBK Northfield Bancorp Inc. (Delaware)
Northfield Bancorp Inc is the holding company for Northfield Bank. Its subsidiary provides banking services to individuals and corporate customers in Richmond and Kings Counties in New York, and Hunterdon, Mercer, Union and Middlesex counties in New Jersey. The bank attracts deposits and offers credit and other banking services.
About PSNL Personalis Inc.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.